SCHEMBL1939941

SCHEMBL1939941

CC(C)n1cc(C(=O)c2cccc(NS(=O)(=O)c3ccc(Cl)cc3Cl)c2Cl)c2c(N)ncnc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.55
EIF2AK3 Q9NZJ5 3/20 0.48
NTRK1 P04629 4/20 0.48
NTRK2 Q16620 3/20 0.48
KCNH2 Q12809 3/20 0.48
NTRK3 Q16288 2/20 0.48
PDPK1 O15530 3/20 0.44
RET P07949 4/20 0.42
LCK P06239 2/20 0.42
SRC P12931 2/20 0.42
SLC40A1 Q9NP59 2/20 0.41
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
ERBB3 P21860 1/20 0.41
ERBB4 Q15303 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1940570 0.93 PDGFRB (0.54) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1940442 0.92 EIF2AK3 (0.51) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1939957 0.91 PDGFRB (0.51) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1941870 0.88 PDGFRB (0.58) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1941454 0.87 PDGFRB (0.55) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1939969 0.87 PDGFRB (0.57) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1941746 0.86 PDGFRB (0.50) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1940475 0.86 PDGFRB (0.70) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1939790 0.86 PDGFRB (0.50) PDGFRBEIF2AK3NTRK1NTRK2KCNH2
SCHEMBL1941376 0.86 EIF2AK3 (0.51) PDGFRBEIF2AK3NTRK1NTRK2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP claimed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US claimed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP claimed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US claimed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO claimed
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP disclosed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 PDGFRB 2465/4885EIF2AK3 2841/4885NTRK1 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.